Company / Net Income
Nurix Therapeutics, Inc. Net Income History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Net Income
-$264.5M
FY2025
5-year range
-$264.5M / -$21.7M
FY2021-FY2025
Trend
-36.6%
vs FY2024
Sector context
#170 of 216
Health Care
What the data says
Nurix Therapeutics, Inc.'s net income of -$264M is lower than 79% of companies in the Health Care sector (FY2025). Net Income has declined for 4 consecutive years, from -$22M in FY2021 to -$264M in FY2025.
Based on SEC 10-K filings.
-$264M in FY2025.
Declined from -$144M to -$264M over the past 2 years.
Health Care sector context is included.
Net Income over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 21% in Health CareTop 79% of 216This company -$264.5M Sector average $454.1M
▼
-158.2% below sector average
Key checks
Key Insights
- Nurix Therapeutics, Inc.'s net income has declined for 4 consecutive years.
- In FY2025, net income decreased 36.6% year-over-year.
- Ranks #170 out of 216 companies in the Health Care sector.
- Peak net income was recorded in FY2021.
Company context
Key Data Points
- Altman Z-Score -0.35 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Net IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$264.5M | -36.6% |
| FY2024 | -$193.6M | -34.5% |
| FY2023 | -$143.9M | -22.8% |
| FY2022 | -$117.2M | -440.1% |
| FY2021 | -$21.7M | +49.8% |
| FY2020 | -$43.2M | -99.3% |
| FY2019 | -$21.7M | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026